Clinical Trial Update: Impact of an Optimized Formulation of Omega 3 on the Composition of Atheromatous Plaques in Patients Requiring Carotid Endarterectomy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial from University Hospital Strasbourg is evaluating whether an optimized formulation of omega-3 fatty acids can alter the composition of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Artery Disease

Drugs mentioned

• Omega-3 fatty acids, optimized formulation (omega-3 fatty acids)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Carotid Endarterectomy | Phase 3 | Status: UNKNOWN